In the long-term, with progression of the illness, Parkinson's disease dementia affects up to
90% of patients with Parkinson's disease. With increasing life expectancy in western …

There is controversy regarding the definition and characteristics of mild cognitive impairment
in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to …

Abstract Background The Montreal Cognitive Assessment (MoCA) was developed to enable
earlier detection of mild cognitive impairment (MCI) relative to familiar multi-domain tests like …

Introduction There is an urgent need to validate telephone versions of widely used general
cognitive measures, such as the Montreal Cognitive Assessment (T‐MoCA), for remote …

Objective: To establish the diagnostic accuracy of the Montreal Cognitive Assessment
(MoCA) when screening externally validated cognition in Parkinson disease (PD), by …

Background Cognitive impairment is a common nonmotor manifestation of Parkinson's
disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive …

Aim: The Montreal Cognitive Assessment (MoCA), developed by Dr Nasreddine
(Nasreddine et al. 2005), is a brief cognitive screening tool for detecting older people with …

Abstract The Montreal Cognitive Assessment (MoCA) is a cognitive screening instrument
developed to detect mild cognitive impairment (MCI). It is a simple 10 min paper and pencil …

Objective To determine effects of Argentine tango on motor and non-motor manifestations of
Parkinson's disease. Design Randomized control trial. Participants Forty patients with …

Background Identifying factors influencing phenotypic heterogeneity in Parkinson's Disease
is crucial for understanding variability in disease severity and progression. Age and gender …